EN
HI
Kabra Drugs Chart
Kabra Drugs Share Key Metrics
Volume
46212.00
Market Cap
61.17 CR
LTQ@LTP
7@26.03
ATP
25.82
Var Margin
25 %
Circuit Range
24.51-27.09
Delivery %
99.9 %
Value
11.93 L
ASM/GSM
No
Market Lot
1
Summary
At 2 Apr, 2026 | 15:29, Kabra Drugs share price stands at ₹26.03, showing a 0.23% 0.89 for the day. The stock’s intraday movement has stayed between ₹25.37 and ₹26.95, while on a 52-week basis it has fluctuated from ₹10.56 to ₹35.52.
In terms of trading activity, Kabra Drugs has recorded a volume of 46212 shares, with a market capitalisation of ₹23707850. The stock’s Average Traded Price (ATP) stands at ₹2582, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 7,2603. The stock operates within a circuit range of ₹24.51-27.09, with a Value of ₹11.93 L. The Delivery Percentage for the day is 99.9%. Additionally, Kabra Drugs currently falls under the No framework, and trades with a market lot size of 1.
Kabra Drugs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
60.59
Sector P/B
3.25
Sec. Div. Yield
0.59
Kabra Drugs Resistance and Support
Pivot 25.39
Resistance
First Resistance
26.2
Second Resistance
26.61
Third Resistance
27.42
Support
First Support
24.98
Second Support
24.17
Third Support
23.76
Kabra Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-03-07 | Others |
| 2026-02-13 | Quarterly Results |
| 2025-11-28 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-10-08 | Others |
| 2025-09-02 | Others |
| 2025-08-14 | Quarterly Results |
| 2025-08-06 | Others |
| 2025-06-18 | Others |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
Kabra Drugs News
Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 07 Th March 2026, As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Kabra Drugs Limited approved changing its name to Aanjaay Industries Limited and formed a strategic joint venture with PT. Bhinneka Dwi Persada for defence technology development and manufacturing in Indonesia. This partnership supports "Make in India" and bilateral ties, focusing on defence procurement and export.
Mar 07 2026 18:03:00
Read More
About Kabra Drugs
NSE : 0
BSE : 524322
ISIN : INE323K01017
Kabra Drugs Management
| Name | Position |
|---|---|
| Mr. N Aravind | Managing Director |
| Mr. Bangalore Venkatakrishnappa Ananth Kumar | WholeTime Director & CFO |
Kabra Drugs Similar Stocks
Deccan Health Care Ltd.
8.25
0.75 (10.00%)
Broach Lifecare Hospital Ltd.
17.39
0.00 (0.00%)
Starsource Multitrade Ltd.
115.90
0.00 (0.00%)
Unjha Formulations Ltd.
20.20
0.70 (3.59%)
Hindustan Bio Sciences Ltd.
8.19
0.39 (5.00%)
Dhanvantri Jeevan Rekha Ltd.
26.90
0.60 (2.28%)
Dr Lalchandani Labs Ltd.
14.81
0.00 (0.00%)
Transpact Enterprises Ltd.
206.70
0.00 (0.00%)
MPS Pharmaa Ltd.
1.65
0.00 (0.00%)
Dolphin Medical Services Ltd.
4.88
0.00 (0.00%)
Kabra Drugs FAQs
The Buying Price of Kabra Drugs share is 26.03 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kabra Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kabra Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kabra Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kabra Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Kabra Drugs’s valuation compare Sector P/E, P/B which are 60.59 & 3.25 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kabra Drugs is 61.17 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kabra Drugs share price is 35.52 & 10.56. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kabra Drugs belongs to the Healthcare sector.
